IFPMA· @IFPMA · X·· 15 天前AI 评分15
AI 导读
目前有 4,700 多种潜在抗癌药物在研发中,中低收入国家的合作是确保这些创新惠及所需人群的关键。@DavidReddyIFPMA 在《Cancer Control 2026》中阐述了投资创新的理由 👇 https://www.cancercontrol.info/cc26-contents/
正文
With 4,700+ potential cancer medicines in development, partnerships in LMICs are key to making sure these innovations reach the people who need them. @DavidReddyIFPMA makes the case for investing in innovation in Cancer Control 2026 👇
https://www.cancercontrol.info/cc26-contents/
来源:IFPMA · x.com